BRNS · Barinthus Biotherapeutics plc.
Market Cap
$30.23M
Shares
40.85M
Volume · Sep 8
378.15K
Avg daily vol (3M)
57.87K
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$0.74
Open$0.74
Day$0.64–0.77
52W close$0.54–1.58
Avg vol 30d71K
Short int13K · 0.0% float · 1.0d
Short vol54%
Last earningsMay 7, 2025
DataApr 2021–Sep 2026
Filing10-Q · Aug 6
Up next
filed Aug 6, 2026
Metrics snapshot
Useful current figures from the complete screener profile.
Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$41.76M
Trailing 12 months
Revenue growth YoY
-100.0%
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
-87.4%
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+1.3%
Year over year · more shares
Price change (1Y)
-39.1%
Trailing year
Short interest
—
Latest settlement
Quarterly results
* Q4 derived as the full year minus Q1 to Q3.
Equibles Rating
blended score · not investment adviceOverall
Sell
SellHoldBuy
Technical
Buy
Momentum
Strong
Sentiment
Neutral
Fundamentals
Poor
Quant / Vol
Very High
Market backdrop
VIX 17.5 · elevated
Equity put/call 0.54
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
+12%
above
Price vs 50-day avg
+18%
above
RSI (14)
60
neutral
MACD trend
Positive
52-week position
19%
mid-range
Momentum
relative strength
1-month return
+32%
trailing
6-month return
+9%
trailing
YTD return
+6%
this year
Relative strength
−5%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +46.2% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
15 holders — mid 3-yr range
Fundamentals
Revenue growth
−100%
Y/Y
EPS growth
−6%
Y/Y
Free cash flow
$-48.0M
Quant / Vol
risk profile
Volatility
79%
annualized · 1-yr
Max drawdown
−66%
past year
ATR
8.5%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Buy
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
+12%
Bullish
Price vs 50-day avg
+18%
Bullish
RSI (14)
60
Neutral
MACD trend
Positive
Bullish
52-week position
19%
Neutral
Market signals — smart money & positioning
Mixed
Trend (MA cross)
No cross
50d $1 › 200d $1 — 200d above 50d
Institutional flow
Accumulating
+7% holders QoQ · +3 funds added
Insider flow
Flat
No net insider activity over 90 days
Short interest
Rising
0.03% of float · ▲ +46.2% MoM · 1.0 days cover
Volume signal
Reversal watch
High volume on a down day — possible exhaustion
Institution breadth
Steady
15 holders — mid 3-yr range
Price context
position in its 52-week range
Range low $1
Now $1 · 19%
Range high $2
vs 200-day avg +12%
vs 50-day avg +18%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
BRNS
this stock
Barinthus Biotherapeutics plc.
|
$30.23M | +5.7% | -100.0% | — | 0.0% |
|
VRTX
Vertex Pharmaceuticals Inc
|
$134.22B | +16.8% | +46.2% | 30.8 | 1.7% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$84.02B | +5.4% | +20.8% | 20.2 | 2.1% |
|
MRNA
Moderna, Inc.
|
$83.03B | +626.2% | +4.3% | — | 8.2% |
|
CSLLY
Csl Ltd
|
$66.80B | — | — | — | 0.0% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| BRNS | +6.2% | +31.7% | +8.8% | +6.2% | +5.7% |
| SPY | -0.1% | -0.9% | +14.2% | -0.1% | +12.3% |
| vs SPY | +6.3% | +32.6% | -5.4% | +6.3% | -6.6% |